ArticleArchives of public health = Archives belges de sante publique2022
Long acting reversible contraceptive utilization and its associated factors among modern contraceptive users in high fertility sub-Saharan Africa countries: a multi-level analysis of recent demographic and health surveys.
Article in Archives of public health = Archives belges de sante publique, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 20 citations in OpenAlex.
- Determinants and predictive modeling of long-acting reversible contraceptive use in Sub-Saharan Africa: evidence from DHS data using machine learning and association rule mining.AJOG global reports · 2026Article
- Household wealth and timing of first birth among highly educated women in sub-Saharan Africa: evidence from survey-adjusted survival analysis.Frontiers in reproductive health · 2026Article
- Clinical effectiveness and side effect profile of contraceptive implant (Implanon) among women at Sulaimaniyah, Iraq: a cross-sectional study.BMC women's health · 2025Article
- Understanding women's preferences for long-acting reversible contraceptives in Gondar, Ethiopia: a discrete choice experiment.Health economics review · 2025Article
- Evaluating long-acting reversible contraceptive service quality at Manna Woreda health posts, Southwest Ethiopia: a mixed method study.Contraception and reproductive medicine · 2025Article
- Long-acting reversible methods of contraception: trends, levels, and predictors among married women of reproductive age in Nigeria.Contraception and reproductive medicine · 2025Article
- Prevalence and factors associated with the use of long-acting reversible and permanent contraceptive methods among women who desire no more children in Bangladesh.Contraception and reproductive medicine · 2025Article
- Long-acting family planning uptake and associated factors among women in the reproductive age group in East Africa: multilevel analysis.Frontiers in global women's health · 2025Article
- Article
- Examining the low uptake of LARC in Ethiopia: an analysis of individual-level predisposing and enabling factors.Frontiers in global women's health · 2025Article
- Predictors of intention to use contraceptives among married and cohabiting women in Ghana: A cross-sectional study.Contraception and reproductive medicine · 2024Article
- Hormonal contraceptive use among women living with hypertension in sub-Saharan Africa: insights from 12 countries.BMC research notes · 2024Article
- Factors that influence modern contraceptive use among women aged 35 to 49 years and their male partners in Gomoa West District, Ghana: a qualitative study.Tropical medicine and health · 2023Article
- Article
- Article
- Intention to use contraceptives and its correlates among reproductive age women in selected high fertility sub-saharan Africa countries: a multilevel mixed effects analysis.BMC public health · 2023Article
- Postpartum long-acting reversible contraceptives use in sub-Saharan Africa. Evidence from recent demographic and health surveys data.PloS one · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLong-acting reversible contraceptives (LARC) have been hailed as one of the safest and most effective methods of contraception. However, the use of LARC is low in the world, including Sub Saharan Africa; therefore, the aim of this study was to assess LARC utilization and associated factors among modern contraceptive users in high fertility SSA countries.
methodsData for this study was obtained from the most recent Demographic and Health Surveys. A total weighted sample of 14,828 reproductive age women was included. A multilevel mixed-effect binary logistic regression model was fitted to identify the significant associated factors of long acting reversible contraception utilization. Finally, the Adjusted Odds Ratio (AOR) with 95% confidence interval was used to declare as statistical significance.
resultsOverall prevalence of LARC utilization was observed to be 20.1% (19.45, 20.74). The factors significantly associated with the utilization were women's age ≥ 35 years (AOR = 1.42; 95% CI: 1.19,1.68), having media exposure (AOR = 1.13; 95% CI: 1.05, 1.28), number of alive children: 1-2 (AOR = 2.35; 95% CI: 1.38, 4.01), 3-4 (AOR = 2.98; 95% CI: 1.74, 5.10), [Formula: see text] 5 (AOR = 2.82; 95% CI:1.63, 4.86), have no history of abortion (AOR = 1.33; 95% CI: 1.17,1.51) and who have no big problem with distance to the health facility (AOR = 1.29; 95% CI: 1.16, 1.43).
conclusionThe use of long acting reversible contraception in this study was relatively low. To improve the utilization of long acting reversible contraceptives governments, policymakers, and stakeholders should implement health promotion strategies through media and improve accessibilities of health facilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.